Spironolactone in the long-term management of patients with congestive heart failure
- 1 January 1980
- journal article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 7 (2) , 131-136
- https://doi.org/10.1185/03007998009112040
Abstract
The therapeutic efficacy of 100 mg spironolactone once daily in patients with congestive heart failure was evaluated in a multi-centre study in general practice. One hundred and fifteen patients were admitted to the study. Clinical and haemotological assessments were made at entry and at regular intervals throughout the 48-week study period. Body weight decreased and the incidence of both pitting and pulmonary oedema was reduced during spironolactone treatment. Plasma sodium level was consistently reduced and plasma potassium increased to accepted normal levels. Seventy-nine patients remained free of side-effects throughout the treatment period.Keywords
This publication has 5 references indexed in Scilit:
- The Effects of Four Months' Treatment with Spironolactone on Systemic Blood Pressure, Cardiac Output and Plasma Renin Activity in Hypertensive PatientsActa Medica Scandinavica, 1977
- DETERIORATION OF GLUCOSE TOLERANCE IN HYPERTENSIVE PATIENTS ON PROLONGED DIURETIC TREATMENTThe Lancet, 1976
- Low doses of hydrochlorothiazide in hypertensionEuropean Journal of Clinical Pharmacology, 1976
- The long-term treatment of hypertension with thiazide diureticsPublished by Oxford University Press (OUP) ,1971
- FURTHER EXPERIENCE WITH SPIRONOLACTONE-HYDROCHLOROTHIAZIDE (ALDACTAZIDE-A) IN THE LONG-TERM TREATMENT OF REFRACTORY CARDIAC EDEMAJournal of the American Geriatrics Society, 1965